info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Parry-Romberg Syndrome Market Share

ID: MRFR//2986-HCR | 115 Pages | Author: Kinjoll Dey| November 2024

Medicine has a unique difficulty with Parry-Romberg Syndrome, a rare disease that damages facial skin and soft tissues. Due to its limited prevalence, organizations seeking market share in this area must use particular methods.
Understanding the target patient demography is crucial to market share positioning. Businesses must do considerable research to discover potential patients, their demographics, and their PRS-specific needs because to its rarity.
Collaborations with medical professionals, dermatologists, and plastic surgeons are crucial. Collaborative networks may identify diseases early and enable efficient communication to inform medical professionals of the best treatments.
Healthcare practitioners must be educated to increase diagnostic knowledge and accuracy. Instructional tools, seminars, and workshops may help professionals recognize PRS indications early, allowing for rapid action.
Programs that educate and assist patients are also essential. Tools and information for potential PRS patients may help develop a community and empower them.
Research and development is crucial for PRS companies looking to create a footprint. A company that consistently develops novel treatment options and therapeutic treatments may become an industry leader.
PRS is unique, thus conventional marketing methods may not work. When marketing strategies are personalized to PRS patients and their families, they make a bigger effect and build brand trust and loyalty.
Gaining market share requires global thinking. Businesses must emphasize global availability since PRS instances are scattered globally. This requires navigating legal situations, understanding cultural nuances, and making the product inexpensive and accessible.
Advocacy and awareness campaigns may change public opinions and earn support. Social media, awareness events, and patient advocacy groups may help a company present itself as a caring and active PRS market player.
Since medicines must be inexpensive for a restricted patient pool while optimizing profitability, smart pricing strategies are essential. Collaboration with healthcare payers and insurers may help create sustainable pricing structures.
To be competitive in the dynamic rare disease industry, companies must be flexible and react to new information, technology, and market trends. To succeed in the PRS market, products, services, and tactics must be updated based on fresh research and patient input.

Parry-Romberg Syndrome Market Scenario 


The Parry-Romberg Syndrome Market is expected to reach USD 923.3 Million by 2030 at 9.6% CAGR during the forecast period 2022-2030. Parry-Romberg syndrome is also known as progressive hemifacial atrophy. It is a rare disease, which is characterized by the shrinking and degeneration of the tissues beneath the skin.


Parry-Romberg Syndrome Market


The changes and deterioration spread slowly and it occurs on one side and rarely extends to other parts of the body. General symptoms, includes facial changes, which involves the tissues above the upper jaw or between the nose and the upper corner of the lip and subsequently progress to the mouth, areas around the eye, the ear, and the neck. Currently, no cure and treatments are available for the parry-Romberg syndrome.


Increasing prevalence of skin diseases, neurological abnormalities, and eye defects are the major driving factors for the growth of the market during the forecast period. Moreover, oral diseases also boost the market growth as the tissues of mouth, including the tongue, gingiva, teeth, and soft palate are commonly involved in Parry-Romberg syndrome.

According to the Centers for Disease Control And Prevention, skin diseases is the most common in the US and over 7% of skin related diseases that are tracked by skin cancer registries are adding fuel to the market growth.  

According to the WHO, millions of people worldwide are affected by neurological abnormalities or disorder. More than 6 million people die because of stroke each year; over 80% of deaths take place in low and middle income countries, which will boost the market growth in developing regions.

On the other hand, high cost of current treatment methods, and long duration for complete cure, for instance, it takes one-two years for facial growth and after facial growth the surgery is proceeded, which may hamper the market growth.   

Parry-Romberg Syndrome Market Segmentation    


The global Parry-Romberg syndrome market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of diagnosis, the market is segmented into physical examination, MRI, serum test, and other.

On the basis of treatment, the market is categorized into drug treatment, surgery, and others. The drug treatment is further segmented into methotrexate, corticosteroids, cyclophosphamide, azathioprine, and others. The surgery is sub-segmented into orthognathic surgery, microsurgical reconstructive surgery, and others.

On the basis of end user, the market is segmented into hospitals & clinics, physical therapists, and others.

Parry-Romberg Syndrome Market Key Players


Some of the key players in parry-romberg syndrome market are: 



  • DePuy Synthes (U.S.)

  • Johnson & Johnson Services, Inc. (US)

  • Medtronic (Ireland)

  • Abbott (US)

  • Immediate Media Company Ltd. (US)

  • Taj Pharmaceuticals Ltd.

  • Pfizer, Inc.

  • Sanofi-Aventis

  • Biogen, Inc.

  • GlaxoSmithKline, Inc.

  • AstraZeneca plc.


Figure: Global Parry-Romberg Syndrome Market, by Region, 2016 (%) Parry-Romberg Syndrome Market-

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation

 

Parry-Romberg Syndrome Market Regional Analysis 


The Americas dominates the global Parry-Romberg syndrome market owing to the presence of huge geriatric population, increasing number of patient with neurological disorder, eye related disorders. Moreover, high healthcare speeding, advanced hospitals infrastructures, availability of skilled healthcare professional are boosting the growth of the market.

Europe accounts for the second largest Parry-Romberg syndrome market across the globe owing to increasing government support for research & development, and increasing investment in healthcare. The countries such as France, and Germany investing in the healthcare to develop new diagnosis and treatment methods for rare diseases, which will boost the market growth. As per Organization for Economic Co-operation and Development (OECD), the share of GDP to health spending in Germany was 11.0% in 2013, compared with a share of GDP was up from 10.8% in 2012, which is responsible for the growth of the market in this region.

Asia Pacific has the fastest growing market, increasing government support for research & development, increasing prevalence of skin diseases, eye related diseases, and huge population base and rapidly developing economy drives the growth of the market in this region. Developing countries in this region are focusing more in the development of healthcare domain for instance country such as India.

The Middle East & Africa is expected to show the least market share due to less availability of medical facilities, and less development in healthcare domain.


Intended Audience



  • Pharmaceutical Companies

  • Medical Devices Manufacturer

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Research Methodology 




Parry-Romberg Syndrome Market Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.